Abstract
OBJECTIVES—In the standard economic model of evaluation, constant discount rates devalue the long term health benefits of prevention strongly. This study shows that it is unlikely that this reflects societal preference. DESIGN—A thought experiment in a cause elimination life table calculates savings of eliminating cardiovascular disease from the Dutch population. A cost effectiveness analysis calculates the acceptable costs of such an intervention at a threshold of 18 000 Euro per saved life year. METHODS—Cause specific mortality (all cardiovascular causes of death and all other causes) and health care costs (all costs of cardiovascular disease and all other causes of costs) by age and male sex of 1994. RESULTS—At a 0% discount rate, an intervention eliminating cardiovascular disease may cost 71 100 Euro. At the same threshold but at discount rates of 3% or 6%, the same intervention may cost 8100 Euro (8.8 times less) or 1100 Euro (65 times less). CONCLUSIONS—The standard economic model needs more realistic duration dependent models of time preference, which reflect societal preference. Keywords: discount rate; time preference; cardiovascular disease
Full Text
The Full Text of this article is available as a PDF (110.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonneux L., Barendregt J. J., Nusselder W. J., der Maas P. J. Preventing fatal diseases increases healthcare costs: cause elimination life table approach. BMJ. 1998 Jan 3;316(7124):26–29. doi: 10.1136/bmj.316.7124.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cairns J. A., van der Pol M. M. Saving future lives. A comparison of three discounting models. Health Econ. 1997 Jul-Aug;6(4):341–350. doi: 10.1002/(sici)1099-1050(199707)6:4<341::aid-hec277>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Drummond M. F., Jefferson T. O. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996 Aug 3;313(7052):275–283. doi: 10.1136/bmj.313.7052.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meerding W. J., Bonneux L., Polder J. J., Koopmanschap M. A., van der Maas P. J. Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study. BMJ. 1998 Jul 11;317(7151):111–115. doi: 10.1136/bmj.317.7151.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Olsen J. A. Time preferences for health gains: an empirical investigation. Health Econ. 1993 Oct;2(3):257–265. doi: 10.1002/hec.4730020309. [DOI] [PubMed] [Google Scholar]
- Weinstein M. C., Stason W. B. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977 Mar 31;296(13):716–721. doi: 10.1056/NEJM197703312961304. [DOI] [PubMed] [Google Scholar]
- West R. R. Discounting the future: influence of the economic model. J Epidemiol Community Health. 1996 Jun;50(3):239–244. doi: 10.1136/jech.50.3.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Hout B. A. Discounting costs and effects: a reconsideration. Health Econ. 1998 Nov;7(7):581–594. doi: 10.1002/(sici)1099-1050(1998110)7:7<581::aid-hec380>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
- van Hout B. A., Goes E. S., Grijseels E. W., Quarles van Ufford M. A. Economische evaluatie binnen de cardiologie; achtergrond en toepassing. Ned Tijdschr Geneeskd. 1998 Sep 19;142(38):2083–2086. [PubMed] [Google Scholar]